Connection

Mike Stedman to Diabetes Mellitus, Type 2

Back to Details
This is a "connection" page, showing publications Mike Stedman has written about Diabetes Mellitus, Type 2.
Mike Stedman
Connection Strength
0.585
Diabetes Mellitus, Type 2
  1. The costs of drug prescriptions for diabetes in the NHS. Lancet. 2019 01 19; 393(10168):226-227.
    View in: PubMed
    Score: 0.171
  2. Sodium-glucose co-transporter-2 inhibitors, the latest residents on the block: Impact on glycaemic control at a general practice level in England. Diabetes Obes Metab. 2018 07; 20(7):1659-1669.
    View in: PubMed
    Score: 0.162
  3. The pattern of prescribing of glucose modulating agents for type 2 diabetes in general practices in England 2016/17. Int J Clin Pract. 2018 Apr; 72(4):e13080.
    View in: PubMed
    Score: 0.161
  4. Age of people with type 2 diabetes and the risk of dying following SARS-CoV-2 infection. Int J Clin Pract. 2021 Aug; 75(8):e14053.
    View in: PubMed
    Score: 0.051
  5. Improving type 2 diabetes mellitus glycaemic outcomes is possible without spending more on medication: Lessons from the UK National Diabetes Audit. Diabetes Obes Metab. 2018 01; 20(1):185-194.
    View in: PubMed
    Score: 0.039
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.